Harbor Capital Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-178,236
| Closed | -$1.19M | – | 1419 |
|
|
2025
Q1 | $1.19M | Buy |
178,236
+13,109
| +8% | +$87.4K | 0.05% | 404 |
|
|
2024
Q4 | $2.08M | Sell |
165,127
-3,379
| -2% | -$42.5K | 0.09% | 275 |
|
|
2024
Q3 | $3.11M | Buy |
168,506
+71,372
| +73% | +$1.32M | 0.14% | 218 |
|
|
2024
Q2 | $2.09M | Buy |
97,134
+15,708
| +19% | +$338K | 0.16% | 190 |
|
|
2024
Q1 | $2.19M | Buy |
81,426
+27,071
| +50% | +$729K | 0.29% | 67 |
|
|
2023
Q4 | $1.63M | Sell |
54,355
-2,962
| -5% | -$88.8K | 0.31% | 83 |
|
|
2023
Q3 | $1.17M | Buy |
57,317
+2,035
| +4% | +$41.7K | 0.25% | 100 |
|
|
2023
Q2 | $1.1M | Buy |
55,282
+2,009
| +4% | +$39.9K | 0.22% | 115 |
|
|
2023
Q1 | $913K | Sell |
53,273
-11,736
| -18% | -$201K | 0.26% | 95 |
|
|
2022
Q4 | $1.27M | Sell |
65,009
-1,401
| -2% | -$27.4K | 1.23% | 26 |
|
|
2022
Q3 | $1.06M | Sell |
66,410
-7,333
| -10% | -$117K | 0.97% | 33 |
|
|
2022
Q2 | $1.02M | Sell |
73,743
-1,434
| -2% | -$19.7K | 0.77% | 38 |
|
|
2022
Q1 | $1.19M | Sell |
75,177
-13,208
| -15% | -$209K | 0.56% | 55 |
|
|
2021
Q4 | $1.93M | Buy |
+88,385
| New | +$1.93M | 0.7% | 46 |
|